Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
4
|
pubmed:dateCreated |
1979-1-24
|
pubmed:language |
jpn
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:month |
Aug
|
pubmed:issn |
0021-4671
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:day |
20
|
pubmed:volume |
13
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
375-86
|
pubmed:dateRevised |
2011-7-28
|
pubmed:meshHeading |
pubmed-meshheading:712166-Complement Inactivator Proteins,
pubmed-meshheading:712166-Complement System Proteins,
pubmed-meshheading:712166-Female,
pubmed-meshheading:712166-Humans,
pubmed-meshheading:712166-Male,
pubmed-meshheading:712166-Neoplasm Staging,
pubmed-meshheading:712166-Neoplasms,
pubmed-meshheading:712166-Prognosis
|
pubmed:year |
1978
|
pubmed:articleTitle |
[Clinical significance of changes of complement-system in malignant diseases (author's transl)].
|
pubmed:publicationType |
Journal Article,
English Abstract
|